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High incidence of initial and late steroid resistance in childhood
nephrotic syndrome.
Background. Conventional wisdom states that greater than
80% of children with nephrotic syndrome (NS) respond to
steroid treatment, remain steroid-sensitive during subsequent
relapses, and consequently have a favorable long-term progno-
sis. In contrast, steroid resistance is believed to be associated
with a high risk of developing chronic renal failure. Recent re-
ports suggest that the histologic pattern of NS in children may be
changing, but whether the change is accompanied by a parallel
change in steroid sensitivity is unknown.
Methods. Initial and subsequent steroid responsiveness was
evaluated in all children aged 1 to 18 years who presented with
newly diagnosed NS to the 2 pediatric nephrology referral cen-
ters in southeastern Louisiana between 1994 and 2003. NS was
defined as presence of edema, heavy proteinuria, and serum
albumin concentration below 2.5 g/dL. Steroid sensitivity (SS)
was defined as total resolution of proteinuria and edema, and
partial response to steroids (PR) was defined as loss of edema
with continuing proteinuria.
Results. There were 210 new cases of NS. Forty-one pa-
tients (20%) had immune complex glomerulonephritis. Six pa-
tients were excluded because of incomplete data availability.
Of the remaining 163 patients, 115 (71%) were SS and 23
(14%) achieved PR during the initial 4 weeks of treatment; 25
(15%) were steroid-resistant (SR). Follow-up data were avail-
able for 91 of the 115 initially SS patients; 19 subsequently
became steroid-resistant. Thus, at least 45% of the patients
with new-onset NS did not have typical childhood steroid-
responsive NS. Initial steroid resistance was more likely in
African American children and in children with older age at
onset (11.5 vs. 4.6 years). Development of steroid resistance
after initial SS was associated with shorter interval to the first
relapse (2.2 vs. 5.4 months) and having the first relapse during
the initial steroid treatment.
Conclusion. Compared to previous reports, our results show
a higher incidence of initial and subsequent steroid resistance,
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characteristics not consistent with typical minimal change NS
with a benign prognosis. The results suggest that in the current
era, NS in children may not be as benign as indicated by earlier
studies.
Nephrotic syndrome (NS) is characterized by mas-
sive proteinuria and hypoalbuminemia, leading to edema
and hypercholesterolemia. In contrast to adults, most
children with NS have idiopathic nephrotic syndrome,
rather than an NS secondary to an immune complex
glomerulonephritis (ICGN). The most common causes
of idiopathic NS in children are minimal change NS
(MCNS) and focal segmental glomerulosclerosis (FSGS).
The groundbreaking International Study of Kidney Dis-
ease in Children (ISKDC), on patients recruited from 3
continents between 1967 and 1976, was the first to report
that MCNS is the most common histopathologic lesion
in renal biopsies from children with idiopathic NS [1, 2].
In contrast, FSGS was a rare cause of NS in children, ob-
served in only 5% to 7% of the biopsies [1–3]. ISKDC also
established the standard initial treatment of idiopathic
NS as 4 weeks of daily steroids, which has been reported
to result in complete remission in 93% to 98% of MCNS
patients but only in 17% to 30% of FSGS patients [3, 4],
yielding an overall response rate in childhood idiopathic
NS of over 80%. Development of steroid resistance after
an initial remission (late steroid resistance) occurred in
only 3.3% of the ISKDC subjects [5].
Several groups have determined the long-term progno-
sis for children with NS [6–8]. Minimal change histology
and steroid responsiveness are usually associated with fa-
vorable prognosis with eventual resolution of the relaps-
ing NS. In contrast, steroid resistance and FSGS histology
often predict high risk of disease progression to chronic
renal failure (CRF). Although not invariable, patients
with steroid resistant NS often exhibit FSGS histology
on biopsy.
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There is evidence that the epidemiology of NS may be
changing. While prior reports have shown that FSGS is
infrequently detected in children with NS, some recent
studies suggest that the incidence of FSGS is increasing
in both pediatric and adult patients [9–14]. The reason
for the apparent increase in incidence is unknown. Those
reports did not systematically examine steroid respon-
siveness of the patients; hence, it is not clear whether the
apparent change in histology is accompanied by paral-
lel changes in sustained steroid responsiveness and long-
term prognosis.
It has been our impression that in our patient pop-
ulation the incidence of steroid-resistant NS is higher
than reported in the literature. To study this question, we
evaluated the incidence of both initial and late steroid
resistance in children who presented with new-onset
NS between 1994 and 2003 to the 2 pediatric tertiary
care centers serving our geographic area, and sought to




Retrospective chart analysis was done to identify all
children who presented with new-onset NS to Children’s
Hospital in New Orleans and Tulane Hospital for Chil-
dren in New Orleans between 1994 and 2003. These 2
centers serve as the only pediatric nephrology referral
centers in an area of approximately 3 million people and
900,000 children. To avoid selection bias, only previously
untreated, newly diagnosed patients were included. Pa-
tients less than 1 year of age (to exclude congenital NS)
or over 18 year of age were excluded from this study.
Definitions and treatment
NS was defined as heavy proteinuria (urine pro-
tein/creatinine ratio >2.0), edema, and hypoalbumine-
mia (serum albumin <2.5 g/dL). All patients except those
diagnosed with ICGN received standard treatment with
daily corticosteroid (prednisone or prednisolone) at a
dose of 2 mg/kg/day (maximum 60 mg/day) for 4 weeks
and were then switched to alternate day therapy.
The response to initial treatment was defined after
4 weeks of daily steroid treatment as follows: (1) steroid-
sensitive (SS), complete resolution of proteinuria and
edema; (2) partial response (PR), resolution of edema
and decrease, but not disappearance, of proteinuria; (3)
steroid resistance (SR), no improvement.
The subsequent steroid responsiveness was evaluated
during the first year following the initial presentation in
patients who had at least 6 months of follow-up using
the same criteria as for initial steroid responsiveness. The
latest follow-up status of each patient is also reported; the
total observation period ranged from 6 to 114 months.
Hypertension was defined as blood pressure higher
than 95th percentile for age according to data from
Task Force Report on High Blood Pressure in Chil-
dren and Adolescents [15]. Hematuria was defined as
a dipstick reading of 1+ or more for blood or as more
than 3 red blood cells per high-power field in urine
sediment. Estimated glomerular filtration rate (GFR)
was calculated by the Schwartz formula: GFR = k ×
height (cm)/plasma creatinine (mg/dL), where k is 0.45
for infants (≤18 months of age), 0.55 for older chil-
dren and adolescent girls, and 0.7 for adolescent boys
over 13 years of age [16]. Decreased kidney func-
tion was defined as GFR <90 mL/min/1.73m2, CRF as
GFR <60 mL/min/1.73m2, and end-stage renal disease
(ESRD) as GFR <15 mL/min/1.73m2 [17].
Pathology
In general, patients who were either suspected on clin-
ical grounds of having NS other than MCNS, or who
were not steroid sensitive underwent percutaneous renal
biopsy. The diagnosis of ICGN was based on positive
immunofluorescence and the presence of electron-dense
“deposits” on electron microscopy. MCNS was charac-
terized by the absence of any conspicuous abnormal-
ity on light microscopy. For the purposes of this report,
FSGS was diagnosed either by the presence of at least
1 glomerulus showing a segmental area of sclerosis, or
by prominent tubular atrophy and interstitial fibrosis
without evidence of immune complex formation. Mesan-
gial hypercellularity (MH) was defined by the presence
prominent mesangial cell proliferation (more than 4 cells
per mesangial area) with increased mesangial matrix
without other conspicuous abnormalities.
Statistical analysis
All data are presented as mean ± standard deviation or
as percentages. Comparison between 2 groups was done
by Student t test and between multiple groups by one-
way analysis of variance (ANOVA) with Tukey’s post-
test. Odds ratios of steroid resistance and 95% confidence
interval were calculated by unconditional logistical re-
gression. Nonparametric variables were analyzed using
Kruskal-Wallis test or Mann-Whitney U test. Compari-
son of independent variables (current study vs. ISKDC
data) was achieved by the Fisher exact probability test.
Statistical significance was defined as P < 0.05. Statisti-
cal analyses were performed with GraphPad Prism Soft-
ware for Science, version 3.00 (GraphPad Software, Inc.,
San Diego, CA, USA) and Stata 7.0 (Stata Corporation,
College Station, TX, USA).
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Incomplete data 
N = 6 
(2.9%)
Prednisone 2 mg/kg/d × 4wks 








































Fig. 1. Summary of patient data. ICGN,
immune-complex glomerulonephritis; SS,
steroid sensitive, PR, partial response to
steroids; SR, steroid-resistant; lost, no
follow-up data available. Initial response
refers to response to the initial 4-week course
of steroids. Subsequent response refers to
steroid responsiveness during the subsequent
course. Summary shows the total of SS, SR,
and ICGN as a fraction of the 136 subjects in
whom follow-up data were available.
RESULTS
Characteristics at onset
There were a total of 210 patients who presented with
new-onset NS (Fig. 1), including those who had ICGN
on biopsy. Of the total group, 108 were males (51%) and
102 were females (49%); 103 were white (49%), 96 were
African American (46%), 6 were Asian (3%), 3 were
Hispanic (1%), and 2 were of mixed ethnicity (1%). The
mean age at onset of NS was 7.2 ± 5.2 years (range 1–
18 years). The mean age of the African American patients
at presentation was significantly higher than that of white
patients (8.2 ± 5.2 vs. 4.3 ± 3.5 years, P < 0.0001). Fifty-
eight patients had hypertension (28%) and 96 patients
had hematuria (46%). The mean serum albumin concen-
tration at presentation was 1.7 ± 0.5 g/dL and 36 patients
(17%) had a reduced GFR. Six patients were excluded
for lack of complete data.
Forty-one patients (19.5%) were found to have an
ICGN (immunoglobulin A nephropathy, membranous
nephropathy, membranoproliferative glomerulonephri-
tis, or lupus nephritis). We did not include their data
among the entire group to assess steroid-sensitivity be-
cause they all did not receive glucocorticoids for 4 com-
plete weeks. Of the ICGN patients, 23 (56%) had hyper-
tension, 31 patients (76%) had hematuria, and 13 patients
(32%) had a decreased GFR. Hypertension, hematuria,
and reduced kidney function were all more frequent in
patients with ICGN than in the rest of the patients as a
group (P < 0.05).
Initial steroid response
One hundred sixty-three patients with idiopathic NS
received the standard initial treatment of 4 weeks of
Table 1. Characteristics of patients with idiopathic nephrotic
syndrome who were steroid-sensitive (SS), showed a partial response
(PR), and were steroid-resistant (SR) after the initial 4 weeks of daily
steroid therapy
SS PR SR
(N = 115) (N = 23) (N = 25) P value
Sex (M:F) 61:52 14:8 11:14 0.50
Race (white:AA)a 65:43 15:6 6:18 0.004b,c
Age at onset years 4.6 ± 3.2 4.7 ± 4.3 11.5 ± 5.4 <0.0001b,c
Hypertension 16 (14%) 6 (26%) 10 (40%) 0.009
Hematuria 40 (35%) 11 (48%) 13 (52%) 0.41
Decreased GFR 9 (8%) 3 (13%) 8 (32%) 0.005
Albumin g/dL 1.6 ± 0.5 1.4 ± 0.5 1.8 ± 0.6 0.10




daily steroids. Initial complete remission was achieved
in 115 patients (71%). Twenty-three patients (14%) had
a PR and 25 (15%) were SR (Fig. 1). In those pa-
tients who achieved a complete remission, the mean time
to response (disappearance of proteinuria) was 2.7 ±
1.3 weeks.
Predictors of initial steroid responsiveness were evalu-
ated as shown in Table 1. To assess the potential effect of
ethnicity on response to steroids, we analyzed the rates of
SS, PR, and SR in our 2 largest groups, whites and African
Americans. We found that SR was more common (P =
0.004) than SS and PR in African American compared
to white patients. However, when examined by uncondi-
tional logistical regression, ethnicity as an independent
risk factor did not reach statistical significance.
For the rest of the parameters displayed in Table 1,
patients from all ethnic groups who received 4 weeks
of steroids were included. Age at onset was a highly
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Table 2. Predictors of subsequent steroid resistance in patients with
an initially steroid-sensitive idiopathic nephrotic syndrome
SS SR
(N = 72) (N = 19) P value
Sex (M:F) 39:33 8:11 0.42
Race (white:AA)a 39:29 13:6 0.61
Age at onset years 4.9 ± 3.5 4.4 ± 2.9 0.58
Hypertension 11 (15%) 4 (21%) 0.70
Hematuria 24 (33%) 9 (47%) 0.20
Decreased GFR 5 (7%) 3 (16%) 0.56
Albumin g/dL 1.6 ± 0.5 1.5 ± 0.5 0.60
Time to initial response weeks 2.6 ± 1.1 2.5 ± 0.9 0.91
1st relapse months 5.4 ± 3.8 2.2 ± 1.4 0.0006
1st relapse while on steroids 21 (29%) 14 (74%) 0.01
aFor this particular data analysis, only white or African American patients
were included.
significant factor; older children were more likely to be
SR. SR patients had a higher prevalence of hyperten-
sion and decreased kidney function. Gender, presence
of hematuria, and serum albumin level did not correlate
with the response to treatment.
Subsequent steroid response
Twenty-four patients who were initially steroid-
responsive were lost to follow-up. Of the 115 children
who were initially steroid-sensitive, 72 (63%) contin-
ued to respond to steroids (Fig. 1). A surprisingly large
number (19 patients, or 17%) developed steroid resis-
tance during subsequent relapses despite being initially
steroid responsive. Of the 23 initial partial responders,
11 patients achieved complete remission with prolonged
steroid therapy and later remained SS. Ten patients de-
veloped steroid resistance, and 2 were lost to follow-
up. Except for 1 patient who was lost to follow-up, all
of the patients who were initially SR continued to be
steroid resistant throughout the study period. In sum-
mary, 53/136 (39%) of the patients continued to exhibit
or developed steroid resistance. Sustained SS was doc-
umented in 83/136 (61%), and if all 24 initially SS who
were lost to follow-up are assumed to have remained SS,
the percentage of subsequent SS patients may be as high
as 66%. Overall, 94/210 (45%) of patients with new-onset
NS had either ICGN or long-term steroid resistance, sug-
gesting a poor prognosis.
Predictors of late steroid resistance were assessed in pa-
tients with initial complete remission (Table 2). Ethnicity
did not predict late steroid resistance. The time period
required for the initial response to steroid treatment was
virtually identical between those who remained SS and
those who developed late SR. In contrast, the time inter-
val from the initial response to the first relapse was sig-
nificantly shorter in patients who developed late steroid
resistance, 2.2 months versus 5.4 months in patients who
continued to be steroid-sensitive (P= 0.0006). In addi-
tion, patients who developed late steroid resistance were
Table 3. Summary of steroid responsiveness and resistance in the
current study and in comparison with ISKDC data
Current study ISKDC
Age at onset years 7.2 ± 5.2a 4.8 ± 2.9
Initial responsiveness% b 70.6a 86.3
Late resistance% c 16.5a 3.3
aP < 0.0001 vs. ISKDC data.
bExcluding patients with ICGN from both studies and comparing patients
who were steroid-sensitive with complete resolution of proteinuria; source of
ISKDC data: reference #4
cSource of ISKDC data from [5].
significantly more likely (P= 0.01) to experience first re-
lapse while receiving steroids. Gender, age at onset, hy-
pertension, hematuria, serum albumin, or kidney func-
tion at onset did not predict late steroid resistance.
Comparison of current data with ISKDC
We sought to compare the rates of initial steroid re-
sponsiveness and late steroid resistance in our patients
to those included in the ISKDC data [4, 5]. It is impor-
tant to note that throughout our study we excluded all
patients with ICGN. In contrast, the ISKDC included
patients with ICGN in their analysis of initial steroid-
responsiveness [4] but excluded patients with ICGN in
their subsequent analysis of late steroid responsiveness
[5]. Thus, a direct comparison between the incidence of
initial steroid responsiveness between our and their study
population could only be done accurately if we elimi-
nated patients with ICGN from their original study. In
summary, we observed a significantly lower rate of initial
steroid responsiveness in our patients. Moreover, even
assuming that all patients lost to follow-up who were ini-
tially steroid-responsive remained responsive, we still ob-
served a significantly higher rate of late steroid resistance
in our patients compared to the IDSKDC patient popu-
lation (Table 3). However, the age at presentation of our
patient population was significantly higher than that re-
ported by the ISKDC [4].
Histopathology
Forty-one patients had ICGN on biopsy. The histologic
diagnoses included lupus nephritis (13 patients), mem-
branoproliferative glomerulonephritis [12], membranous
nephropathy [11], IgA nephropathy [3], and other im-
mune complex glomerulonephritis [2].
Renal biopsy was done in most patients who did not
exhibit sustained steroid responsiveness. Of 23 partial re-
sponders, 14 patients (61%) underwent renal biopsy. Of
these, MCNS was diagnosed in 36%, MH in 43%, FSGS
in 21%. Twenty-four of the 25 patients (96%) who were
initially SR had a renal biopsy done. Of these patients,
MCNS was present in 17%, MH in 8%, and FSGS in 75%.
All the 19 patients with late steroid resistance who were



















Fig. 2. Histologic findings in the patients with initial partial response
(PR), initial steroid resistance (SR), and late steroid resistance (late
SR). FSGS, focal segmental glomerulosclerosis; MH, mesangial hyper-
cellularity; MCNS, minimal change nephrotic syndrome.
initially SS underwent renal biopsy; MCNS was observed
in 47%, MH in 11%, and FSGS in 42% (Fig. 2).
The latest follow-up status
Most patients with idiopathic NS who were resistant
to oral steroids received other antiproteinuric medica-
tions. These included angiotensin-converting enzyme in-
hibitors, angiotensin receptor blockers, alkylating agents
(cyclophosphamide or chlorambucil), high-dose intra-
venous steroids (e.g., “pulse methylprednisolone”), and
calcineurin inhibitors (cyclosporine or tacrolimus).
The latest follow-up status was available in 136 of
the 163 (83%) patients with idiopathic NS, as shown in
Table 4. The follow-up period of these patients ranged
from 6 to 114 months. One hundred and ten patients
were either in prolonged remission or continued to have
relapses; all previously SS patients were included in this
group. Of the 53 previously SR patients, 21 patients had
unremitting NS with normal renal function, while 5 pa-
tients developed CRF, including 2 who progressed into
ESRD. All 5 patients who developed CRF were African
American, initially and subsequently SR, and had a renal
biopsy showing FSGS.
DISCUSSION
Childhood NS was once considered a benign condi-
tion because of the good response to steroid treatment
in the vast majority of patients. Indeed, a comprehen-
sive review of childhood NS showed that the response
rate of childhood NS to steroids has been reported to be
at least 80% in previous studies [18]. Our findings differ
from the results of those studies in several important as-
pects. First, we observed a relatively high (20%) incidence
of ICGN in patients with new-onset NS. Another ma-
Table 4. The latest follow-up status of 136 patients with idiopathic
nephrotic syndrome according to early clinical course
Steroid sensitivity during
the first year after diagnosis
SS SR
Latest status (N = 83) (N = 53)
Prolonged remission or
continuing relapses
83 (100%) 27 (51%)
Unremitting NS 21 (40%)
CRF 3 (5%)
ESRD 2 (4%)
jor finding derived from our study is the relatively lower
rates of initial steroid responsiveness compared to the
ISKDC studies. For our analysis of initial steroid respon-
siveness, we excluded all patients with ICGN. In contrast,
the ISKDC included patients with ICGN in their analysis
of initial steroid-responsiveness [4] but excluded patients
with ICGN in their subsequent analysis of late steroid
resistance [5]. Thus, a direct comparison between the in-
cidence of initial steroid responsiveness between our and
their study population could only be done accurately if we
eliminated patients with ICGN from their original study.
Excluding all patients with ICGN, the response rate in
our patients to the initial course of steroids was 71%. In
contrast, 86% of patients with NS but without ICGN re-
sponded to the initial course of steroids in the ISKDC
study [4]. It is important to re-emphasize that although
initial steroid-responsiveness was reported by the ISKDC
to be 78%, this figure included patients with ICGN.
Another significant difference between our and the
ISKDC study is that according to current practice stan-
dards, all of our patients received 4 weeks of steroids
during the initial presentation of NS compared to some
patients in the ISKDC study who received 8 weeks of
steroids. One could argue that the lower rates of ini-
tial steroid-responsivenes in our patients may be due, in
part, to the shorter course of steroids received by some
of our patients. However, close analysis of the ISKDC
data reveals that very few patients in the ISKDC study
achieved remission after the initial 4-week period [4].
Finally, the progression to steroid resistance after ini-
tial steroid responsiveness, a rare occurrence in previous
reports, was relatively common (17%). This was signifi-
cantly higher than reported by the ISKDC [5]. Overall,
45% of newly presenting NS patients did not have typical
steroid-responsive childhood NS.
Thus, our data, collected on patients who presented
during the most recent decade, strongly suggest that the
epidemiology of steroid responsiveness in childhood NS
is changing. We believe that our results reflect the true
epidemiology of NS in our population for the follow-
ing reasons. First, our 2 centers are the only pediatric
nephrology referral centers in southeastern Louisiana,
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and our informal survey has established that almost all
pediatric patients with NS are referred by the primary
care physicians. Second, including only previously un-
treated patients removes the possibility of selection bias
toward steroid-resistant patients. Based on our data, we
estimate that the minimum incidence of childhood NS in
our geographic area is approximately 2.3 new cases/105
children per year; it may be slightly higher because we
excluded a few patients who were previously treated by
their primary care physician. This incidence is compara-
ble to the previously reported incidence of childhood NS
of 2.0 new cases/105 children per year in the United States
[19] and slightly lower than a recently reported incidence
from Canada [11]. Thus, it appears that there has not been
a large increase in the incidence of NS in general, but that
there may be a shift toward steroid resistance.
Predictors of initial steroid resistance in our study were
age at onset, hypertension, and decreased kidney func-
tion. Older age at the time of initial presentation was as-
sociated with a higher risk of steroid resistance. The age of
our patients at presentation was significantly higher than
the cohort included in the ISKDC study [4]. We hypoth-
esize that age may have been a very important factor in
determining the higher incidence of steroid resistance in
our patient cohort compared to the ISKDC. Indeed, Baqi
et al reported that FSGS is more common in older (older
than 6 years of age) versus younger (less than 6 years of
age) children with NS [23]. Thus, our results are consis-
tent with prior reports showing that older children and
adolescents have a higher incidence of FSGS and steroid
resistance [4, 22].
Another major factor that may have resulted in the
higher rate of steroid resistance in our patients was the
high proportion of African American patients in our
study population compared to the ISKDC population.
However, although African Americans are reported to
have a higher incidence of FSGS [20, 21], the associa-
tion of age with steroid resistance in our material was
still present after corrected for ethnicity. This is in agree-
ment with the described increase in FSGS in Caucasian
children in Canada [11]. Even though ethnicity did not
reach statistical significance as an independent risk fac-
tor for steroid resistance in our subjects, this may be due
to the limited number of subjects. Forty-six percent of
our patients were African Americans and they comprised
the majority of those who were steroid-resistant. Thus, it
seems reasonable to state that the higher incidence of ini-
tial steroid-resistance in our study versus the ISKDC is
likely due, in part, to the higher percentage of African
American patients in our cohort. In contrast, our data
suggest the incidence of late steroid resistance is not af-
fected by ethnicity. One major confounding factor in the
analysis of the effect of ethnicity on steroid resistance
is the fact that the age at presentation of our African
American patients was almost twice that of the white pa-
tients; thus, it seems reasonable to speculate that a major
factor causing the higher rate of steroid resistance in our
patient population is the combined effect of ethnicity and
older age.
An important new finding in our study was the surpris-
ingly high number of patients who developed late steroid
resistance during subsequent relapses despite being ini-
tially steroid responsive. This subsequent resistance usu-
ally occurred between 1 month and 1 year after the initial
episode. There are scant reports describing late steroid
resistance in children with NS, all studied before 1990
[5, 6, 24, 25]. Those reports show that only 1% to 5%
of children with NS develop late steroid resistance after
initial steroid responsiveness. For example, the ISKDC
study reported that only 3.3% of initial responders de-
veloped late steroid resistance [5]. We assessed various
potential predictors of late steroid resistance in our pa-
tients. We found that an early relapse after the initial
remission and the occurrence of the first relapse while
receiving the initial course of steroids were predictive
factors for late steroid resistance. Ethnicity was not pre-
dictive of late steroid resistance, although it did predict
initial steroid responsiveness.
Until recently, MCNS has been considered the pre-
dominant pathology in children with NS. However, since
1999, several reports have suggested that the incidence
of FSGS may be increasing in children and adults [9–
14]. According to those reports, FSGS is now estimated
to account for 22% to 46% of childhood idiopathic NS.
Because the present study was not a prospective investi-
gation including renal biopsies in all patients, we cannot
make any definitive statements regarding the overall inci-
dence of FSGS, or the relationship between steroid resis-
tance and histopathology. However, we did observe that
a majority of patients who were steroid-resistant and who
had a renal biopsy performed had FSGS. Interestingly, al-
most half of the patients with partial response to steroids
showed MH on biopsy, which has been suggested to be
an early marker for developing FSGS [26, 27]. Moreover,
a significant percentage of steroid-resistant patients had
MCNS histology; this agrees with previous reports that
have shown that minimal change histology is not invari-
ably associated with steroid responsiveness [28], some-
times progressing into FSGS on follow-up biopsies [27,
29, 30].
The follow-up period of our report is not long enough
to determine the long-term prognosis, especially the per-
centage of patients progressing into ESRD. However,
unremitting NS or proteinuria is generally considered a
poor prognostic sign in idiopathic NS. Despite the rel-
atively short follow-up, 5 patients developed renal fail-
ure or ESRD; all had been classified as steroid-resistant.
At the latest follow-up, 81% were either in prolonged
remission or continued to have relapses while 19% re-
mained resistant to all treatment. Some patients who
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were initially steroid resistant apparently responded to
other immunosuppressive medications. However, all of
the patients who had unremitting NS at the latest follow-
up had been steroid resistant at some point during the
entire first year of analysis. Based upon this observation,
we speculate that steroid responsiveness during the first
year likely predicts each patient’s subsequent course. The
ISKDC study [5] also reported that the early course is one
important factor predicting the ultimate outcome.
CONCLUSION
Our data show that steroid-responsive idiopathic NS is
less common in children with newly diagnosed NS than
previously reported. The reasons for the change in epi-
demiology are not clear, but it does not appear to be due
to overall increase in the incidence of NS in childhood.
Hence, we conclude that the risk of steroid resistance in
childhood NS may be higher than generally believed. This
may have implications for long-term prognosis.
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